FATE · Fate Therapeutics Inc · Documents
Market Cap
$248.03M
Shares
119.82M
Volume · Oct 21
1.22M
Avg daily vol (3M)
1.61M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-09-28 | 2026-09-25 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| 8-K | — | 2026-06-15 | 2026-06-12 | |
| 8-K | — | 2026-06-04 | — | |
| 8-K | — | 2026-05-13 | — | |
| 10-Q | — | 2026-05-13 | 2026-03-31 | |
| ARS | — | 2026-04-24 | 2025-12-31 | |
| DEFA14A | — | 2026-04-24 | — | |
| DEF 14A | — | 2026-04-24 | 2026-06-12 | |
| 8-K | — | 2026-02-26 | — | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 10-Q | — | 2025-11-13 | 2025-09-30 | |
| 8-K | — | 2025-11-13 | — | |
| 8-K | — | 2025-10-27 | 2025-10-26 | |
| 8-K | — | 2025-10-14 | 2025-10-10 | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-08-12 | 2025-08-07 | |
| 8-K/A | — | 2025-06-17 | 2025-05-29 | |
| 8-K | — | 2025-05-30 | 2025-05-29 | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| ARS | — | 2025-04-17 | 2024-12-31 | |
| DEFA14A | — | 2025-04-17 | — | |
| DEF 14A | — | 2025-04-17 | 2025-05-29 | |
| PRE 14A | — | 2025-04-07 | 2025-05-29 | |
| 8-K | — | 2025-03-05 | — | |
| 10-K | — | 2025-03-05 | 2024-12-31 | |
| 8-K | — | 2025-01-06 | 2024-12-31 | |
| 8-K | — | 2024-11-29 | 2024-11-27 | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| 8-K | — | 2024-08-30 | 2024-08-26 | |
| 8-K | — | 2024-08-13 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-07-31 | 2024-07-29 | |
| 8-K | — | 2024-06-10 | 2024-06-07 | |
| 8-K | — | 2024-06-07 | 2024-06-03 | |
| 8-K | — | 2024-05-31 | 2024-05-30 | |
| 8-K | — | 2024-05-09 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEFA14A | — | 2024-04-26 | — | |
| DEF 14A | — | 2024-04-26 | 2024-06-07 | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| S-3 | — | 2024-04-18 | — | |
| PRE 14A | — | 2024-04-16 | 2024-06-07 | |
| 8-K | — | 2024-03-21 | 2024-03-19 | |
| 10-K | — | 2024-02-26 | 2023-12-31 | |
| 8-K | — | 2024-02-26 | — |
Showing 1–50 of 118 filings
Key facts
CIK
1434316
CUSIP
31189P102
13F (30d)
15 filings
15 filers
Visit website
Investor relations